Clinical Trial

Closed-blood Sampling Devices in the Adult Critically Ill Patient

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 10, 2025 (before its estimated June 7, 2026 completion). Its status may not reflect the trial's current state.
Summary
Based on the hypothesis that the strategy of using Closed-Blood Sampling Devices (CSBD, experimental group) compared to the usual practice (waste discard volume, control group), in critically ill adult patients, will decrease the amount of blood withdrawn for laboratory tests, we want to analyze the number of red blood cells (RBC) administered and arterial catheter-related adverse events (catheter-related bacteremia, catheter obstruction, CBSD malfunction, loss of arterial pressure waveform on the patient's bedside monitor) in both study groups, during ICU stay and up to a maximum of 21 days.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-21.
Status change: Not Yet Recruiting → Recruiting 2025-11-06
Trial Details
NCT Number NCT06478160
Lead Sponsor University of Barcelona
Collaborators: Hospital Universitario 12 de Octubre, Hospital Universitario Rey Juan Carlos, Hospital General Universitario Gregorio Marañon, Hospital Universitario Virgen Macarena
Conditions Acceptability of Health Care
Enrollment 216 participants
Start Date 2024-11-11
Primary Completion 2026-06-07 (estimated)
Study Completion 2026-06-07 (estimated)
Updated on ClinicalTrials.gov 2025-11-10